4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000065
Chief Commercial Officer sold 2,770 shares at $33.54 ($92,906)
- Chief Commercial Officer acquired 6,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Milanova Tsveta · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,000 | 28,892 | D | ||
| 2025-06-24 | Sale : show line 2 in the form 10b5-1 | −2,770 | $33.54 | $92,906 | 26,122 | D |
| Open-market sales · 2,770 sh · avg $33.54 · $92,906 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-24 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −6,000 | 6,000 | D |
Loading xslF345X05/wk-form4_1750972990.xml…